A hedge fund board member filed $317M in CVS stock sales this week. Larry Robbins, who holds a board seat at CVS Health, unloaded 3.37 million shares between May 19–21. The trades were filed on May 21. At roughly $94 per share, it is one of the largest insider disposals seen in recent weeks.
CVS's own CTO, Tilak Mandadi, also sold $6.2M in stock earlier this month, filed on May 11.
The contrast at NCLH — Norwegian Cruise Line Holdings — is stark. Five separate directors filed purchases totalling over $1.5M in the past two weeks. Jonathan Cohen bought 30,000 shares at $15.83 on May 20. José Eduardo Cil picked up 15,000 shares across two trades near $15. It signals that the board sees value at current prices.
Elsewhere, Capital Group disclosed a $285M stake build in ONC — BeOne Medicines — filed May 22 after buying 943,000 shares at around $302.
At BLFS, hedge fund Casdin Partners sold $28M of BioLife Solutions stock across three days, filed May 21.
Six CMI Cummins insiders sold a combined $8.1M, all filed within the past ten days.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
